LeBlanc Thomas W, Temel Jennifer S, Helft Paul R
From the Cancer Patient Experience Research Program, Duke Cancer Institute, Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC; Massachusetts General Hospital, Boston, MA; Department of Medicine, Division of Hematology/Oncology, Indiana University Melvin and Bren Simon Cancer Center, Indiana University School of Medicine, Indianapolis, IN.
Am Soc Clin Oncol Educ Book. 2018 May 23;38:787-794. doi: 10.1200/EDBK_201211.
Prognostication is the science by which clinicians estimate a patient's expected outcome. A robust literature shows that many patients with advanced cancer have inaccurate perceptions of their prognosis, thus raising questions about whether patients are truly making informed decisions. Clinicians' ability to communicate prognostic information is further complicated today by the availability of novel, efficacious immunotherapies and genome-guided treatments. Currently, clinicians lack tools to predict which patients with advanced disease will achieve an exceptional response to these new therapies. This increased prognostic uncertainty on the part of clinicians further complicates prognostic communication with patients. Evidence also suggests that many oncologists avoid or rarely engage in prognosis-related communication and/or lack skills in this area. Although communication skills training interventions can have a positive impact on complex communication skills for some clinicians, there is no one-size-fits-all approach to improving patient-clinician communication about prognosis. Yet improving patient understanding of prognosis is critical, because patient understanding of prognosis is linked with end-of-life care outcomes. Solutions to this problem will likely require a combination of interventions beyond communication skills training programs, including enhanced use of other cancer clinicians, such as oncology nurses and social workers, increased use of palliative care specialists, and organizational support to facilitate advance care planning.
预后评估是临床医生估计患者预期结果的一门科学。大量文献表明,许多晚期癌症患者对自己的预后存在不准确的认知,这就引发了关于患者是否真的在做出明智决策的疑问。如今,新型有效免疫疗法和基因组导向治疗的出现,使临床医生传达预后信息的能力变得更加复杂。目前,临床医生缺乏预测哪些晚期疾病患者会对这些新疗法产生特殊反应的工具。临床医生预后不确定性的增加,进一步使与患者的预后沟通变得复杂。证据还表明,许多肿瘤学家避免或很少进行与预后相关的沟通,和/或在这方面缺乏技能。尽管沟通技能培训干预措施可能会对一些临床医生的复杂沟通技能产生积极影响,但对于改善医患之间关于预后的沟通,并没有一种适用于所有情况的方法。然而,提高患者对预后的理解至关重要,因为患者对预后的理解与临终关怀结果相关。解决这个问题可能需要多种干预措施的结合,而不仅仅是沟通技能培训项目,包括更多地利用其他癌症临床医生,如肿瘤护士和社会工作者,增加姑息治疗专家的使用,以及提供组织支持以促进预先护理计划。